Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Joe Krupa who wrote (7558)	7/28/2001 2:33:17 PM
From: Montana Wildhack	Read Replies (1) \| Respond to of 14101

I have an announcement. This August 2001 is a once in a lifetime opportunity. It's not ever coming back exactly like August 1989 didn't. We should forget stock we're not going to sell anyways, get out there and create a memory. We can carp about not being satisfied when the winter's here. BTW - I read on Stockhouse someone looked up that DMX is publishing August 06. Also lets remember FDA approval for Pennsaid does not HAVE to go through the August or October meetings. That forum is not a necessary step so much as an issue resolution group. Secondly, the upgrades being made to plant production sound to me like they are material enough to require an inspection on behalf of all approving bodies. Finally, I have no idea how much of that $7 billion US market to add into the model on top of Pennsaid for WF10. (That was a 1996 number). 5% in 2 years? $350 million US? I understand partnerships here could be much less relevant - as is sales effort. So in total...what...$700 million Cdn in sales DMX level 2-3 years from now. 60-70% margin? Say 400 WF10 and 300 Pennsaid? Way below 5% for each on penetration. Maybe $240 million after tax. Call it 60 million shares fully diluted. $4 EPS. $60 Cdn shareprice? (15x) What the h*ll. Say 2004 and $3 EPS and $45. I don't hear layoffs, and reduce to core businesses, and sales slowdowns. I hear expansion, acquisition, cash needs, and the long suffering relationships with approving bodies. Heard yesterday it was the EU that screwed up - DMX and MCA both did what they were supposed to do and got shocked. Wolf